NSD3 and squamous cell lung carcinoma: NSD3 has also been proposed as an oncogenic driver in non-small cell lung cancer (NSCLC) [11], lung squamous cell carcinoma (LUSC) [36] and pancreatic ductal adenocarcinoma (PDAC) where the 8p11-12 amplicon has also been found.